ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
ElevateBio has raised $401.0M in total funding. The most recent round was Series D. The last funding was announced in May 2023.
ElevateBio's investors include Novo Nordisk, Samsara BioCapital, Redmile Group, Vertex Ventures, Fidelity.
ElevateBio is headquartered in Waltham, United States.
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
ElevateBio is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ElevateBio — Funding & Investors." VCBacked, May 24, 2023, https://www.vcbacked.co/company/elevatebio. Accessed September 29, 2026.
VCBacked. (2023). ElevateBio — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/elevatebio
{{cite web |title=ElevateBio — Funding & Investors |url=https://www.vcbacked.co/company/elevatebio |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated